Unusual Skin Carcinomas Induced by BRAF Inhibitor for Metastatic Melanoma: A Case Report

The most frequently reported skin tumours during treatment with targeted therapies for BRAF (B type Rapidly Accelerated Fibrosarcoma kinase) mutated metastatic melanoma are squamous cell carcinomas (SCCs). Basal cell carcinomas (BCCs) have been described in such setting, but no cases of multiple and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Diagn Res
Autors principals: Cavalieri, Stefano, Di Guardo, Lorenza, Cossa, Mara, Cimminiello, Carolina, Del Vecchio, Michele
Format: Artigo
Idioma:Inglês
Publicat: JCDR Research and Publications (P) Limited 2017
Matèries:
Oncology Section
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5583902/
https://ncbi.nlm.nih.gov/pubmed/28893027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7860/JCDR/2017/26881.10200
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars